
Nammi Therapeutics
Operator of an immunotherapy company intended to provide improved treatment of cancer. The company combines immune-modulating prodrugs into lipid nanoparticles for selective delivery to tumors as well...
Valuation
$75M
Latest known
Share Price
N/A
Total Raised
$66.5M
Last Round
N/A